Adverse Event Reporting

VAERS ID	1393329
Gender	Female
Age
StateCode	FR
Pharmaceutical Company	PFIZER\BIONTECH
Lot Number
Number of vaccinations	1
Vaccinated
Onset	2021-05-24
Condition

Symptoms

• Heavy menstrual bleeding

Current Illness

Preexisting Conditions

Medical History/Concurrent Conditions: Pregnancy

Other Medications

Previous Vaccinations

Allergies

Laboratory Data

Write-up

heavy periods; Prolonged heavy periods; This is a spontaneous report from a contactable consumer.
This is a report received from the regulatory authority report number GB-MHRA-WEBCOVID-202105262258281680-XD0FS.
Safety Report Unique Identifier is GB-MHRA-ADR 25368651.
A 41-year-old female patient first dose of received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation.
Medical history included pregnancy.
Patient had not had symptoms associated with COVID-19.
Not had a COVID-19 test.
Patient was not enrolled in clinical trial.
The patient's concomitant medications were not reported.
The patient experienced heavy periods large clots on an unspecified date and prolonged heavy periods on 24May2021.
The events were reported as serious (Other medically important condition).
Patient has not tested positive for COVID-19 since having the vaccine.
The patient had not recovered from prolonged heavy periods while outcome of heavy periods was unknown.
No follow-up attempts are possible; information about lot/batch number cannot be obtained.